Atlas Trials

Assessing the Safety of Buprenorphine in People With Sickle Cell Disease

Clinical trial NCT03492099 · COMPLETED

Trial details

NCT number
NCT03492099
Sponsor
Johns Hopkins University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2018-08-01
Primary completion
2019-09-23
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.